Evotec Biologics advances orthopoxvirus antibodies into Phase 1
Evotec Biologics advanced U.S. Department of War antibodies against orthopoxvirus into Phase 1 clinical studies.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.